There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
The improvement in the life expectancy of women with breast cancer raises important
questions about how to improve the quality of life for women sustaining complications
of breast cancer treatment. In particular, attention to common problems, such as arm
edema, is of critical importance. We reviewed published breast cancer guidelines and
literature identified via MEDLINE(R) searches in an effort to summarize the research
literature pertinent to management of breast cancer-related arm edema, including incidence,
prevalence, and timing; risk factors; morbidity; prevention; diagnosis; and efficacy
of nonpharmacologic and pharmacologic interventions. We found that arm edema is a
common complication of breast cancer therapy that can result in substantial functional
impairment and psychological morbidity. The risk of arm edema increases when axillary
dissection and axillary radiation therapy are used. Recommendations for preventive
measures, such as avoidance of trauma, are available, but these measures have not
been well studied. Nonpharmacologic treatments, such as massage and exercise, have
been shown to be effective therapies for lymphedema, but the effect of pharmacologic
interventions remains uncertain. Comparing results across studies is complicated by
the fact that the definitions of interventions and measures of outcomes and risk stratification
vary substantially among studies. As arm edema becomes more prevalent with the increasing
survival of breast cancer patients, further research is needed to evaluate the efficacy
of preventive strategies and therapeutic interventions.
Axillary lymph node dissection for staging the axilla in breast carcinoma patients is associated with considerable morbidity, such as edema of the arm, pain, sensory disturbances, impairment of arm mobility, and shoulder stiffness. Sentinel lymph node biopsy electively removes the first lymph node, which gets the drainage from the tumor and should therefore be associated with nearly zero morbidity. Postoperative morbidity (increase in arm circumference, subjective lymphedema, pain, numbness, effect on arm strength and mobility, and stiffness) of the operated arm was prospectively compared in 35 breast carcinoma patients after axillary lymph node dissection (ALND) of Level I and II and 35 patients following sentinel lymph node (SN) biopsy. Patient characteristics were comparable between the two groups. Postoperative follow-up was 15.4 months (range, 4-28 months) in the SN group and 17.0 months (range, 4-28 months) in the ALND group. Following axillary dissection, patients showed a significant increase in upper and forearm circumference of the operated arm compared with the SN patients, as well as a significantly higher rate of subjective lymphedema, pain, numbness, and motion restriction. No difference between the two groups was found regarding arm stiffness or arm strength, nor did the type of surgery affect daily living. SN biopsy is associated with negligible morbidity compared with complete axillary lymph node dissection. Copyright 2000 American Cancer Society.
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.